Top 25 Medical VC Funds & Investors in Portugal (July 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Portugal Ventures
VC Fund
|
10 | Portugal, United States, France | Seed, Pre-Seed | Software, Information Technology, Health Care | $107k–$2.1M |
|
Armilar Venture Partners
VC Fund
|
5 | Portugal, United States, United Kingdom | Seed, Series A | Software, Information Technology, Artificial Intelligence | $500k–$17M |
|
Vesalius Biocapital Partners
VC Fund
|
4 | Belgium, Germany, France | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $3.8M–$100M |
|
TheVentureCity
VC Fund
|
3 | United States, Spain, Brazil | Seed, Pre-Seed, Series A | Software, SaaS, Artificial Intelligence | $100k–$18M |
|
Caixa Capital
VC Fund
|
3 | Portugal, United States, Spain | Seed, Series A, Series B | Software, SaaS, Information Technology | $120k–$23M |
|
Biovance Capital
VC Fund
|
3 | Portugal, The Netherlands | Seed, Series A | Medical, Biotechnology, Product Research | |
|
Critical Ventures
VC Fund
|
2 | Portugal, United States, Germany | Seed, Series A, Series B | Software, Artificial Intelligence, Health Care | $1.2M–$19M |
|
SOSV
VC Fund
|
2 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
Demium Capital
VC Fund
|
1 | Spain, Portugal, Poland | Pre-Seed, Seed, Series A | Software, FinTech, Health Care | $110k–$3.1M |
|
HTGF (High-Tech Gruenderfonds)
VC Fund
|
1 | Germany, Switzerland, United States | Seed, Series A | Software, Biotechnology, Information Technology | $1.1M–$33M |
|
Green Innovations
VC Fund
|
1 | Portugal | Series A | Medical, Genetics, Health Care | |
|
Iberis Capital
VC Fund
|
1 | Portugal, United States, Spain | Seed, Series A, Series C | Information Technology, Software, Artificial Intelligence | $1.2M–$147M |
|
Shilling VC
VC Fund
|
1 | Portugal, Spain, United States | Seed, Pre-Seed, Series A | Information Technology, Software, Internet | $208k–$20M |
|
Boehringer Ingelheim Venture Fund
VC Fund
|
1 | United States, Germany, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $1.8M–$50M |
|
ChangePartners
VC Fund
|
1 | Portugal | Seed | Medical, Therapeutics, Biotechnology | |
|
Social Impact Fund
VC Fund
|
1 | Spain, Portugal, United States | Seed, Debt Financing | Apps, Video, Finance | $942k–$2.5M |
|
BlueCrow Capital
VC Fund
|
1 | Portugal, United Kingdom, Spain | Venture - Series Unknown, Seed, Series A | Information Technology, SaaS, Energy | $1.6M–$18M |
|
Artesian VC
VC Fund
|
1 | Australia, United States, Hong Kong | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Health Care | $40k–$15M |
|
AngelsWay
VC Fund
|
1 | Portugal | Seed | E-Commerce, Art, Pet | $59k–$704k |
|
COREangels
VC Fund
|
1 | Spain, Portugal, United States | Seed, Pre-Seed, Series A | Software, SaaS, Information Technology | $150k–$17M |
|
Explorer Investments
VC Fund
|
1 | Portugal, Spain, Brazil | Private Equity, Seed, Series A | Manufacturing, Retail, Health Care | $2.1M–$16M |
|
FSNB Health & Care
VC Fund
|
1 | ||||
|
Boule Diagnostics
VC Fund
|
1 | Portugal | Series A | Medical, Health Care, Medical Device | |
|
OrbiMed
VC Fund
|
1 | United States, China, Israel | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $10M–$151M |
|
Torrey Pines Investment
VC Fund
|
1 | United States, Russian Federation, The Netherlands | Seed, Pre-Seed | Biotechnology, Health Care, Pharmaceutical | $3M–$3.1M |
| Access all 40 VC funds in Portugal Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Verticals:Enterprise, SaaS, Security, Networks, AI, VR/AR, Marketplace, Blockchain, Internet of Things, New materials, Electronics, Robotics, Cleantech, Agrotech, Seatech, Therapeutics, Digital Health, Diagnostics, Innovative Accommodation, Tourist Entertainment Companies, Tour Operators, Wine, Nautical and Equestrian Tourism, Theme ParksMobile, Robotics Founded in 2012, Portugal Ventures is a venture capital firm based in Porto, Portugal. The firm is a part of the Banco Português de Fomento group. The firm seeks to invest in pre-seed, seed and series A stages
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Pre-Seed
- Geography: Portugal, United States, France
Investor stats
- Total investments: 261
- Round size: Seed $110k–$2.1M; Pre-Seed $107k–$658k
- Lead/follow: 13% lead, 87% follow
- Last fund: May invest from a new fund soon — last raise in 2011
Portfolio highlights
- EatTasty — Fresh food delivery service in Lisbon. Easy to choose and order. Free delivery. Discover our delicious lunches and dinners!
- Unlockit — Unlockit will offer to public and governmental bodies the guarantee that everything within a real estate transaction is recorded, meaning better industry regulation, more taxes and public fees collected, and less overall fraud and money laundering activities.
- Codeplace — The best place to develop your coding skills with a comprehensive, specially curated list of tutorials and books.
Armilar Venture Partners is Portugal's leading venture capitalist. An independent VC with a 20-year-old history, a high-performance track record and an international footprint, Armilar is a deep-tech investor in ICT, HealthTech and CleanTech.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A
- Geography: Portugal, United States, United Kingdom
Investor stats
- Total investments: 105
- Round size: Seed $500k–$4.8M; Series A $4M–$17M
- Lead/follow: 38% lead, 62% follow
- Last fund: May invest from a new fund soon — raised $53M in 2019
Portfolio highlights
- Airflows — Airflows is a platform offering private AI solutions for back-office operations, enabling the creation of applications, workflows, and agent assistants from documents, rules, and approvals while maintaining full control, auditability, and integration with existing systems like ERP, ECM, and BPM.
- DOJO AI — Dojo AI is pioneering the Marketing Operating System (MOS) category, providing challenger brands with enterprise-grade marketing infrastructure. Its proprietary technology combines real-time market intelligence, specialized AI agents, and automated workflow orchestration in one unified platform.The Dojo MOS enables marketing teams to run theirentire operation - from market research and strategy to content creation and campaign execution - through a single, intelligent system. The platform features a proprietary graph engine for real-time market intelligence, marketing-specific language models, and autonomous AI agents trained for specialized marketing tasks.Built for challenger brands looking to compete more effectively, Dojo eliminates the need for multiple point solutions and reduces dependency on external agencies. The platform continuously learns and optimizes, providing companies with compounding advantages as they scale their marketing operations.
- DareData —
Vesalius Biocapital Partners invests in companies active in human health through venture capital funds raised since 2007. They have contributed to developing 20 companies since inception.With more than € 150 million under management in two funds. Vesalius Biocapital Partners plays the role of lead investor in the large majority of its financingrounds.Their companies are based in Europe allowing easy interaction with management.They invest in all stages of development and do not shy away from relatively early-stage projects with a sound proprietary technology and corresponding IP, unique team skills and a clear competitive edge based on solid data.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: Belgium, Germany, France
Investor stats
- Total investments: 61
- Round size: Series A $3.8M–$20M; Series B $4.4M–$27M; Series C $7M–$100M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Nutrium — Nutrium is the most up-to-date nutrition software for dietitians and nutritionists to manage their nutrition business with nutritional assessment, meal planning and progress tracking.
- ENYO Pharma — ENYO Pharma is a biopharmaceutical company incorporated in Jan, 2014, by four scientists of the Infectiology Research Center in Lyon, France, and three seeding partners (2 privates and 1 public).The company is based in the Infectiology Center of Lyonbiopôle in Lyon, France and maintains tight collaborations with the seminal Inserm team and theBSL4 laboratory Inserm-Jean Mérieux.ENYO Pharma has licensed several Inserm patents issued from the discoveries of the founding scientists and developed a unique platform for the identification of intracellular therapeutic targets and molecules.The company is developing treatments against the most important viruses and is thriving to become a global leader in anti-virals. Research and Development is currently focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company plans to conduct its molecules to Phase II clinical trials.
- Inflammatix — Inflammatix develops rapid point of care diagnostic tests by reading the immune system, and resolves major clinical health challenges.
TheVentureCity is a global early-stage venture fund, investing in product-centric startups across the US, Europe, and Latam. With more than $150M under management, the firm invests from pre-seed and seed with a ticket size from $100-500k to Series A with $1-4M.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Spain, Brazil
Investor stats
- Total investments: 136
- Round size: Seed $100k–$4.9M; Pre-Seed $100k–$1.2M; Series A $3M–$18M
- Lead/follow: 13% lead, 87% follow
- Last fund: May invest from a new fund soon — last raise in 2021
Portfolio highlights
- Argo — Argo is a transit technology and services company that provides an integrated public transportation system, combining electric vehicles, intelligent routing software, and operational management to offer on-demand transit services. Its products and services include smart routing technology, EV transit vehicles, and mobile app-based ride matching forcommunities.
- Belo — Crypto for everyone, everyday
- Sidekick — Expertly-managed portfolios for the modern investor
Caixa Capital is the Private Equity and Venture Capital arm of banking Group Caixa Geral de Depósitos and has a track record spanning over two decades of activity, since the industry was created in Portugal. It is a leading investor in terms of funds under management, portfolio size and diversity.Caixa Capital´s mission is to invest in fundsand companies, led by highly qualified management teams, with high growth and valuation potential, that enable our funds to achieve an attractive risk adjusted return and for society at large to benefit sustainably from our activity.Currently with more than 700 million Euros under management and a portfolio of over 80 investments, Caixa Capital is a reference in this area with special links to the respective European sector associations.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Series A, Series B
- Geography: Portugal, United States, Spain
Investor stats
- Total investments: 74
- Round size: Seed $120k–$2.5M; Series A $3M–$12M; Series B $1.1M–$23M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Veniam — Transfer 10x more data for your video telematics, fleet operations, industrial IoT or connected vehicles.
- Growappy — Growappy is an EdTech that offers an all-in-one platform for early education that is leading a vision to unlock personalized education since nursery with the power of AI, while providing a revolutionary communication experience between schools and families and drastically simplifying bureaucracy for teachers and school owners.
- Infraspeak — Infraspeak is an Intelligent CMMS Software that brings outstanding flexibility, connectivity and intelligence to your operations.
Biovance Capital is a new € 51M fund to invest in early-stage biotech companies across Europe developing innovative therapeutics in all disease areas and drug modalities (small and large molecules, vaccines, cell, and gene therapies).
Show more...Investment focus
- Industry: Medical, Biotechnology, Product Research
- Stage:Seed, Series A
- Geography: Portugal, The Netherlands
Investor stats
- Total investments: 4
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Laigo Bio — Laigo Bio uses E3 ligase internalization to precisely degrade membrane proteins linked to autoimmune and inflammatory disorders.
- Mondego Bio — Headquartered in Portugal’s main biotech park, Biocant, Mondego Bio is developing best-in-class protein tyrosine phosphatase non-receptor type 2 (PTPN2) inhibitors, providing a potential immuno-oncological therapy with an improved safety and tolerability profile.
We invest in game-changing companies with the power to transform the way the world uses technology.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A, Series B
- Geography: Portugal, United States, Germany
Investor stats
- Total investments: 8
- Round size: Seed $1.2M–$13M; Series A $2.6M–$19M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Deltia — We use computer vision and AI analytics to provide insights into manual assembly processes - our platform supports process engineers in driving productivity and quality of assembly processes
- Twinzo —
- RunSafe Security — Secure embedded systems with RunSafe Security's runtime cybersecurity protection, integrating build-time defenses without affecting performance.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Demium is a talent investment company founded in Spain in 2013 with the aim of supporting the best professionals and helping them to carry out successful projects, always with an eminently digital and technological component. In November 2020, it's asset management company, Demium Capital, started operating with a first €50M fund to invest inmore than 75 early-stage startups per year (pre-seed/seed), becoming the most active venture capital fund in Spain. Startups such as Hannun, Voicemod, Swipcar, Citibox, Singularu or Landbot, among others have been created in the incubator. The company is present in five countries: Spain, Portugal, Poland, Ukraine and Czech Republic
Show more...Investment focus
- Industry: Software, FinTech, Health Care
- Stage:Pre-Seed, Seed, Series A
- Geography: Spain, Portugal, Poland
Investor stats
- Total investments: 84
- Round size: Seed $110k–$3.1M; Pre-Seed $110k–$574k
- Lead/follow: 61% lead, 39% follow
- Last fund: May invest from a new fund soon — raised $52M in 2020
Portfolio highlights
- Rauda AI — Rauda is an artificial intelligence platform specialized in automating customer service with the best customer experience. Take a quantum leap in productivity, reduce costs and improve customer satisfaction with the power of generative artificial intelligence.
- Aino — AI-powered site analysis for real estate professionals. Generate feasibility studies with quantified metrics, maps, cost estimates, and zoning insights in minutes, no GIS or coding required.
- Orbital Paradigm —
High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 583
- Round size: Seed $1.1M–$7.3M; Series A $3.5M–$33M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — raised $522M in 2022
Portfolio highlights
- DcubeD — Accelerate your space exploration through durable and affordable Release Actuators, Solar Arrays, and Deployables from DCUBED.
- FINE Legal — fine. holt Dir Dein Geld einfach, digital und ohne Risiko.
- NAVAN Technologies — NAVAN Technologies, Inc., (NAVAN) is a pre-clinical stage biotechnology company developing and commercializing its proprietary NanoStraw platform technology, which establishes a direct, physical connection into cells to overcome a huge challenge faced by researchers globally: delivering material into hard-to-transfect-cells in an efficient yetgentle and non-perturbative manne
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!International, Life Sciences, Biotechnology
Show more...Investment focus
- Industry: Medical, Genetics, Health Care
- Stage:Series A
- Geography: Portugal
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- CBR Genomics — We apply our end-to-end solutions to hand genetic reports at the clinical desk. We make Genomics accessible!
Iberis is an investment manager that operates a value-oriented investment management.
Show more...Investment focus
- Industry: Information Technology, Software, Artificial Intelligence
- Stage:Seed, Series A, Series C
- Geography: Portugal, United States, Spain
Investor stats
- Total investments: 51
- Round size: Seed $1.2M–$3.2M; Series A $5.8M–$41M; Series C $16M–$147M
- Lead/follow: 45% lead, 55% follow
Portfolio highlights
- Infos —
- TEKEVER — The Tekever Group is a provider of innovative technologies in Software, Aerospace, Defence and Security Markets.
- Reckon.ai — Whether you're building an unattended store or supplying the equipment behind it, Reckon's patented AI technology transforms existing infrastructure into smart, autonomous assets.
Shilling is an early-stage venture capital firm backing exceptional founders from the start.Shilling invests in a wide range of verticals and seeks out the biggest opportunities across all B2B and consumer categories. Leveraging the concept of Founder LPs, Shilling brings much more than capital and offers through its Shilling Platform, directaccess to successful founders and executives of leading companies. This platform supports entrepreneurs in validating and developing their ventures, which then accelerate their growth into global markets.
Show more...Investment focus
- Industry: Information Technology, Software, Internet
- Stage:Seed, Pre-Seed, Series A
- Geography: Portugal, Spain, United States
Investor stats
- Total investments: 89
- Round size: Seed $603k–$5M; Pre-Seed $208k–$3M; Series A $5M–$20M
- Lead/follow: 24% lead, 76% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Algori — Improving FMCG growth with the fastest and most granular insights from 45,000 shoppers in Spain
- Tucuvi — Tucuvi is a digital health startup on a mission to make healthcare efficient and accessible so all patients can have the best life quality at home. We offer a virtual care platform based on Lola, the first AI voice-based virtual nurse that accompany and monitor health status of patients by naturally speaking with them via phone calls.
- Punto Health — AI-Powered, Personalised Support for Every Patient and Family
Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 100
- Round size: Seed $1.8M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
- Lead/follow: 48% lead, 52% follow
- Last fund: May invest from a new fund soon — raised $250M in 2018
Portfolio highlights
- Perfood — Perfood is a digital therapeutic startup that identifies what actions need to take on a personalized level, to prevent or fight diseases. Using sensors, lab results, and holistic analyses, they derive therapeutic angles and deliver them in a slick, easy-to-use way, making them accessible for all patients. They call this approach digitaltherapeutics. A digital solution that is just as effective as a drug. But without side effects.
- ArrePath — ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.
- Brainomix — Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providingreal-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.
ChangePartners is an independent company dedicated to mid-size transactions in the Iberian market. They develop high value added solutions specific to each particular situation , offering a fair and unbiased opinion. Their independence guarantees no conflicts of interest. Their small size and focus ensures full dedication to each transaction.
Show more...Investment focus
- Industry: Medical, Therapeutics, Biotechnology
- Stage:Seed
- Geography: Portugal
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Exogenus Therapeutics — Exogenus Therapeutics is engineering cell biology for innovative therapeutic solutions.Exo-T is a biotechnology company dedicated to the pre-clinical and clinical development of innovative cellular-based therapies applied to regenerative medicine, specifically for the skin lesions treatment. The company is presently developing its first product,Exo-Wound, for the treatment of chronic wounds.The project that led to the creation of the company (Nanoinspire) participated in COHiTEC 2014 program and is the result of the research developed in collaboration with Crioestaminal SA, Biocant, and Centre for Neurosciences and Cellular Biology of Coimbra University.
SIF provides financial support for public charities & acts as a fiscal agent for charities and foundations.
Show more...Investment focus
- Industry: Apps, Video, Finance
- Stage:Seed, Debt Financing
- Geography: Spain, Portugal, United States
Investor stats
- Total investments: 4
- Round size: Seed $942k–$2.5M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Criam — CRIAM stands for Chemical Reaction and Image Analysis for Mobility. We are a Medtech startup born in January 2016 focused in the Point-of-Care diagnostic segment. Our mission is to provide fast, affordable and in-situ blood test analysis to empower people with instant information about their well-being and health conditions. With our device as aplatform approach we will be able to monitor, control and contain diseases worldwide.
- tuTECHÔ — tuTECHÔ is an innovative social enterprise born with the purpose of contributing to the eradication of homelessness in Spain.
- MemoryWell — MemoryWell is a digital platform for storytelling that brings the skills of professional writers to the challenge of helping elders tell their life story. With MemoryWell+, you can build a collaborative timeline around that story, adding photos, videos, letters and documents. Everyone has a story, let us help you capture it.
BlueCrow Capital is a venture capital firm.
Show more...Investment focus
- Industry: Information Technology, SaaS, Energy
- Stage:Venture - Series Unknown, Seed, Series A
- Geography: Portugal, United Kingdom, Spain
Investor stats
- Total investments: 22
- Round size: Seed $1.6M–$10M; Series A $6.5M–$16M; Venture - Series Unknown $8.2M–$18M
- Lead/follow: 41% lead, 59% follow
Portfolio highlights
- Bighub — The All-in-One Platform for european marketplace growth. Integration, Catalog SEO, Pricing, Financing, Logistics, Helpdesk, and Resale.
- Bling Energy — Bling Energy is a startup that focuses on providing more efficient and sustainable energy solutions, mostly through solar panels.
- TWEVO Technologies — Solutions for i4.0 | Detection + Supervision + Control State-of-the-art AI video processing and encoding, ultra-fast Edge-AI electronics implementations complement and strengthen real-time factory worker responses, optimised video processing and transmission to provide full video information on the factory floor.
Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Australia, United States, Hong Kong
Investor stats
- Total investments: 246
- Round size: Seed $135k–$4.6M; Pre-Seed $40k–$1.5M; Series A $2.3M–$15M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Vaulta — Discover Vaulta's high-performance batteries for sustainable energy solutions. Revolutionising power with easy installation, maintenance, and recycling. Join the Australian-made energy revolution today!
- Andromeda Robotics — At Andromeda, our personalised robot companions are helping Australian aged care teams bring joy and connection to residents to improve wellbeing.
- Infiction labs — SPARC 1.2 is a solar panel robotic cleaning system designed and developed by Infiction Labs Pvt Ltd for commercial solar plants.
Discover the power of community-driven investing with Angels Way - a Portugal-based organization dedicated to fostering the growth and success of early-stage startups. By providing funding, resources, and support, we empower technology-driven companies to make a real difference in the world. Join us in our mission to drive innovation and change through the next generation of startups in Portugal.
Show more...Investment focus
- Industry: E-Commerce, Art, Pet
- Stage:Seed
- Geography: Portugal
Investor stats
- Total investments: 6
- Round size: Seed $59k–$704k
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Curiouz — Curiouz is a tech-enabled platform dedicated to source, authenticate and deliver iconic vintage furniture pieces for interior designers, collectors, and design lovers. We bring together a unique selection of items combining sustainability, craftsmanship, and technology. Discover unique items that elevate interiors.
- WiseWorld — Design roadmaps. Evaluate and grow. From recruitment to L&D.
- Hands On — Hands On is a marketplace for on-site workshops.
Where startups can get much more than money, and Investors can professionally invest as angels.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: Spain, Portugal, United States
Investor stats
- Total investments: 57
- Round size: Seed $271k–$5.2M; Pre-Seed $150k–$1.4M; Series A $15M–$17M
- Lead/follow: 11% lead, 89% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Pawer — B2C insurance subscription for pet owners
- hypt — hypt is a Swiss based SaaS marketing solution that empowers companies to digitalize word-of-mouth. By using our word-of-mouth manager companies are able to activate 40% of their customers to send out a personal recommendation to their peers increasing sales through word-of-mouth by 4 times. Our solution empowers our ICP customers in the finance andinsurance segments to strategically use and optimize the most authentic and cost effective advertising channel – word-of-mouth – and makes it an accessible asset of every marketing mix.
- Ex Nunc Intelligence — Ex Nunc Intelligence provides professionals with thorough summaries of legal information, credible responses to legal issues, and automated legal document preparation features.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Founded in 2003, Explorer is Portugals leading independent management company of alternative assets, with a reputation for outstanding quality, in-depth experience and an excellent track record.
Show more...Investment focus
- Industry: Manufacturing, Retail, Health Care
- Stage:Private Equity, Seed, Series A
- Geography: Portugal, Spain, Brazil
Investor stats
- Total investments: 70
- Round size: Seed $2.1M–$11M; Series A $7M–$16M
- Lead/follow: 76% lead, 24% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- Feedzai — Stop financial crime before it happens. Feedzai's AI-powered platform detects and prevents fraud, money laundering, and other risks across all channels.
- Luca — Luca's learning platform provides learning programs for primary and secondary school students. The learning platform offers pre-recorded K12 videos, gamified content and AI powered personalized study paths, covering the entire official academic curriculum and national exams prep. Luca is a VC backed startup with HQ in Madrid & MexicoCity
- Spotlite — Spotlite combines satellite data with AI to predict infrastructure risks before they become problems.
FSNB Health & Care is a strategy consulting firm that specializes on healthcare. FSNB Health & Care collaborates with all healthcare stakeholders, including institutions, experts, hospitals, healthcare operators, unions and professional orders, pharmaceutical laboratories, medical device industries, complementary health insurance,healthcare industry providers, patient associations, biotechnology companies, and health start-ups.
Show more...Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Tonic App — Tonic App is a B2C2B digital health company building a professional ecosystem for medical doctors. Tonic App helps medical doctors to diagnose and treat their patients by curating, for them, in a single mobile platform, the best professional resources from peers, publishers, regulatory bodies, recruiters, providers & the industry.
Boule develops, manufactures, and markets hematology analyzers for both human and veterinary markets. Read more about us here.
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Series A
- Geography: Portugal
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Biosurfit — At biosurfit they are working to shape the future of in-vitro diagnostic testing. They want health providers to have all the necessary information to make the best possible diagnostic and treatment decision when they are with their patients
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, China, Israel
Investor stats
- Total investments: 611
- Round size: Series A $10M–$140M; Series B $24M–$151M; Series C $15M–$131M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- MDClone — The MDClone ADAMS Platform is a self-service, data analytics environment powering healthcare collaboration, innovation, and data-driven projects.
- Beijing Tianxing — Beijing Tianxing is a clinical solutions company for sports medicine for implants, arthroscopy devices, and sports medicine equipment.
- Aspen Neuroscience — personalized cell therapy Starts with you Learn More about our technology
Torrey Pines Investment, founded in 2002, is a specialty life-science investment company located in San Diego.Torrey Pines has a team of investment professionals with extensive experience in entrepreneurship, venture capital and operations. Our firm has created biopharma incubators investing in early development stage assets from internationalpharma and biotech partners in CNS, oncology, and virology areas to bring them to commercial success through pharma partnering and M&A.We are committed to capitalizing on the unique opportunities in biotech and pharma, where we can add value in development or regulatory strategy by utilizing resources of our portfolio CRO companies. We seek to leverage our industry knowledge, network of industry and financial contacts, and internal resources to assist our portfolio management in developing and executing their business strategy. Our bottom line is to help our companies achieve growth, build value and realize wealth.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Seed, Pre-Seed
- Geography: United States, Russian Federation, The Netherlands
Investor stats
- Total investments: 32
- Round size: Seed $3M–$3.1M
- Lead/follow: 19% lead, 81% follow
- Last fund: May invest from a new fund soon — raised $60M in 2017
Portfolio highlights
- Mondego Bio — Headquartered in Portugal’s main biotech park, Biocant, Mondego Bio is developing best-in-class protein tyrosine phosphatase non-receptor type 2 (PTPN2) inhibitors, providing a potential immuno-oncological therapy with an improved safety and tolerability profile.
- BIMINI Biotech — BIMINI Biotech is a startup that develops innovative therapeutic strategies for oncology. It is developing therapeutic strategies that target the growth hormone receptor (GHR) and its interaction with insulin-like growth factor 1 (IGF-1) for oncology, metabolic diseases, and aging.The company was founded in 2019 and is based in Leiden, TheNetherlands.
- Chromis Therapeutics — Chromis Therapeutics, Inc. (Chromis) is a San Diego-based biopharmaceutical company, focused on the development of curative treatments for chronic HBV infection, based on its advanced proprietary drug design and discovery platform. The company is seeking investment to advance its novel cccDNA inhibitor (CHR101), viral entry and viral capsidassembly inhibitor lead candidates for the treatment of chronic HBV. CHR101 has a potential to eradicate HBV and to efficiently cure chronically infected HBV patients, as compared to drugs currently on the market. CHR101's activity is supported by a robust discovery preclinical data package.
Medical VC funding in Portugal at a glance
Stats across 39 deals from 40 investors.
Access all 40 VC funds in Portugal Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical VC Funds in Portugal investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 40 VC funds investing in Portugal Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!